139 related articles for article (PubMed ID: 24393995)
1. [A case of recurrent rectal cancer successfully treated for a long period with capecitabine plus oxaliplatin and bevacizumab therapy].
Iwata N; Ishikawa T; Takahashi H; Baba H; Masuda D; Okazaki S; Matsuyama T; Ishiguro M; Kobayashi H; Iida S; Uetake H; Sugihara K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2008-10. PubMed ID: 24393995
[TBL] [Abstract][Full Text] [Related]
2. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
[TBL] [Abstract][Full Text] [Related]
3. [A case of locally advanced colorectal cancer with abscess responding to 5-fluorouracil, leucovorin, and oxaliplatin plus bevacizumab].
Kuwabara H; Watanabe S; Liu B; Mitsuoka A; Sanada T; Nakajima K; Goseki N
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2032-4. PubMed ID: 24394003
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial.
Uehara K; Hiramatsu K; Maeda A; Sakamoto E; Inoue M; Kobayashi S; Tojima Y; Yoshioka Y; Nakayama G; Yatsuya H; Ohmiya N; Goto H; Nagino M
Jpn J Clin Oncol; 2013 Oct; 43(10):964-71. PubMed ID: 23935207
[TBL] [Abstract][Full Text] [Related]
5. [A case of cecum colon cancer with lymph node metastasis successfully treated with XELOX plus bevacizumab].
Ito S; Ichikawa R; Kure K; Honjo K; Aoki J; Okazawa Y; Mizukoshi K; Ro H; Kawai M; Takehara K; Okubo H; Ishiyama S; Sugimoto K; Komiyama H; Takahashi M; Yaginuma Y; Kojima Y; Goto M; Tomiki Y; Sakamoto K
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1425-8. PubMed ID: 25434448
[TBL] [Abstract][Full Text] [Related]
6. Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study.
Nagasaka T; Mishima H; Sawaki A; Shimokawa M; Inukai M; Shinozaki K; Tanioka H; Nasu J; Nishina T; Hazama S; Okajima M; Yamaguchi Y
BMJ Open; 2016 Jun; 6(6):e011454. PubMed ID: 27256093
[TBL] [Abstract][Full Text] [Related]
7. [Retrospective analysis of the bevacizumab and CapeOX combination in untreated metastatic/recurrent colorectal cancer].
Miyamae Y; Takahashi K; Igarashi T; Tanaka K; Takahashi N; Hirai K; Tsukagoshi H; Ogawa H; Yoshinari D; Sunose Y; Takeyoshi I
Gan To Kagaku Ryoho; 2014 Jun; 41(6):737-41. PubMed ID: 25129085
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
[TBL] [Abstract][Full Text] [Related]
9. Practical use of capecitabine plus oxaliplatin (CAPEOX) with bevacizumab for patients with metastatic colorectal cancer that cannot expect conversion therapy.
Yokomizo H; Yoshimatsu K; Otani T; Osawa G; Nakayama M; Matsumoto A; Yano Y; Okayama S; Naritaka Y
Hepatogastroenterology; 2013; 60(128):1911-5. PubMed ID: 24719926
[TBL] [Abstract][Full Text] [Related]
10. [A case of descending colon cancer with multiple liver metastases effectively treated with capecitabine/oxaliplatin (CapeOX) and bevacizumab].
Nakano M; Kameyama H; Shimada Y; Hashimoto Y; Hosoi M; Nakano M; Nogami H; Hanyu T; Takizawa K; Ishikawa T; Sakata J; Kobayashi T; Minagawa M; Kosugi S; Koyama Y; Wakai T
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1785-7. PubMed ID: 25731329
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative chemotherapy enabled radical resection of tumors in a patient with multiple liver metastases].
Shimizu K; Doi K; Ogawa K; Iwatsuki M; Tanaka H; Sugiyama S; Ogata K; Takamori H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1743-5. PubMed ID: 25731315
[TBL] [Abstract][Full Text] [Related]
12. [A case of a recurrent hepatic metastasis occurred after curative resection of ascending colon cancer and a hepatic metastasis responding completely to capecitabine plus bevacizumab].
Murayama M; Kohno T; Miyazawa M; Shimazaki A; Miyaki A; Usuda A; Asaka S; Yamaguchi K; Yokomizo H; Shiozawa S; Yoshimatsu K; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2014-6. PubMed ID: 24393997
[TBL] [Abstract][Full Text] [Related]
13. [A resected case of locally invasive rectal cancer successfully treated with neoadjuvant capecitabine, oxaliplatin, bevacizumab and radiation therapy].
Suzuki S; Shigaki N; Yokoyama S; Yamashita H; Sugita H; Arima N
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1545-7. PubMed ID: 21918360
[TBL] [Abstract][Full Text] [Related]
14. [A case of Stage IV sigmoid colon cancer cured with radical combined modality therapy].
Babaya A; Fukunaga M; Yamamoto T; Oda K; Nakata K; Ohzato H
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1956-8. PubMed ID: 24393978
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study.
Hochster HS; Hart LL; Ramanathan RK; Childs BH; Hainsworth JD; Cohn AL; Wong L; Fehrenbacher L; Abubakr Y; Saif MW; Schwartzberg L; Hedrick E
J Clin Oncol; 2008 Jul; 26(21):3523-9. PubMed ID: 18640933
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer with multiple metachronous metastasis achieving complete remission 14 years after surgical resection: report of a case.
Murono K; Kawai K; Kazama S; Tsuno NH; Sunami E; Kitayama J; Watanabe T
Int Surg; 2013; 98(1):49-54. PubMed ID: 23438276
[TBL] [Abstract][Full Text] [Related]
17. [Two cases of locally advanced colorectal cancer curatively resected after neoadjuvant chemotherapy with 5-fluorouracil, leucovorin, and oxaliplatin plus panitumumab].
Nakayasu Y; Yoshimatsu K; Yokomizo H; Osawa G; Yano Y; Nakayama M; Sakuma A; Yamaguchi K; Shiozawa S; Shimakawa T; Katsube T; Naritaka Y
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2029-31. PubMed ID: 24394002
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Heterochronic Ovarian Metastasis from Sigmoid Colon Cancer after Sigmoidectomy Treated with CapeOX That Included Bevacizumab].
Ono R; Ise N; Yoshioka H; Iwasaki W; Sato K; Niwa M
Gan To Kagaku Ryoho; 2017 Jan; 44(1):83-85. PubMed ID: 28174387
[TBL] [Abstract][Full Text] [Related]
19. [Eighty-five-year-old patient with recurrent rectal cancer effectively treated with CapeOX chemotherapy].
Shimada Y; Sakamoto T; Oyamatsu M; Sato K; Tani T
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1213-5. PubMed ID: 21772115
[TBL] [Abstract][Full Text] [Related]
20. [A case of primary duodenal cancer recurrence successfully treated with CapeOX therapy].
Miyamoto M; Kirii Y; Takagi H
Gan To Kagaku Ryoho; 2014 Apr; 41(4):495-8. PubMed ID: 24743368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
